Recent INTS News
- Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award • PR Newswire (US) • 05/14/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:10:14 PM
- Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/07/2026 08:06:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 08:07:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 08:06:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:06:12 PM
- Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation • PR Newswire (US) • 04/15/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:13:39 PM
- Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update • PR Newswire (US) • 03/27/2026 08:12:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2026 08:01:10 PM
- Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US • PR Newswire (US) • 03/24/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:02:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/23/2026 08:00:51 PM
- Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study • PR Newswire (US) • 03/12/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 01:04:30 PM
- Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement • PR Newswire (US) • 03/06/2026 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:07:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:00:16 PM
- Intensity Therapeutics Announces Reverse Stock Split • PR Newswire (US) • 02/13/2026 01:58:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2026 09:18:14 PM
- Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities • PR Newswire (US) • 01/13/2026 12:47:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:03:34 PM
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium • PR Newswire (US) • 12/11/2025 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 12:33:29 PM
